Friday at ASCO: Glioma and Biosimilar TrastuzumabFriday at ASCO: Glioma and Biosimilar Trastuzumab

Among the news highlighted today is a study showing improved survival in patients with glioma and a biosimilar product for trastuzumab (Herceptin). Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news